BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO

0001193125-18-186947.txt : 20180607 0001193125-18-186947.hdr.sgml : 20180607 20180607170912 ACCESSION NUMBER: 0001193125-18-186947 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 16 FILED AS OF DATE: 20180607 DATE AS OF CHANGE: 20180607 EFFECTIVENESS DATE: 20180607 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BLACKROCK FUNDS CENTRAL INDEX KEY: 0000844779 IRS NUMBER: 510318674 STATE OF INCORPORATION: MA FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 033-26305 FILM NUMBER: 18887259 BUSINESS ADDRESS: STREET 1: 100 BELLEVUE PARKWAY CITY: WILMINGTON STATE: DE ZIP: 19809 BUSINESS PHONE: 800-441-7762 MAIL ADDRESS: STREET 1: 100 BELLEVUE PARKWAY CITY: WILMINGTON STATE: DE ZIP: 19809 FORMER COMPANY: FORMER CONFORMED NAME: COMPASS CAPITAL FUNDS\ DATE OF NAME CHANGE: 19961114 FORMER COMPANY: FORMER CONFORMED NAME: PNC FUND DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: NCP FUNDS DATE OF NAME CHANGE: 19890511

0000844779 S000001877 BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO

C000004912 INSTITUTIONAL SHSSX

C000004913 SERVICE SHISX

C000004914 INVESTOR A SHSAX

C000004916 INVESTOR C SHSCX

C000037661 R Shares

C000172900 Class K

497 1 d591164d497.htm BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO

LOGO

SIDLEY AUSTIN LLP

787 SEVENTH AVENUE

NEW YORK, NY 10019

+1 212 839 5300

+1 212 839 5599 FAX

AMERICA • ASIA PACIFIC • EUROPE

June 7, 2018

VIA EDGAR

Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

Re:

BlackRock Health Sciences Opportunities Portfolio, a series of BlackRock Funds^SM

(File Nos. 33-26305, Investment Company Act No. 811-05742)

Ladies and Gentlemen:

On behalf of BlackRock Funds^SM, attached for filing are exhibits containing interactive data format risk/return summary information that mirrors the risk/return summary information in the Supplement to the Summary Prospectuses, Prospectuses and Statement of Additional Information of BlackRock Health Sciences Opportunities Portfolio (the “Fund”), each dated January 26, 2018, as filed pursuant to Rule 497(e) under the Securities Act of 1933 on May 17, 2018 (the “497 Filing”). The purpose of this filing is to submit the 497 Filing in XBRL for the Fund.

Any questions or comments on the 497 Filing should be directed to the undersigned at (212) 839-8615.

Very truly yours,

/s/ Jesse C. Kean

Jesse C. Kean

Enclosures

cc:	Benjamin Archibald, Esq.

BlackRock Advisors, LLC

Sidley Austin (NY) LLP is a Delaware limited liability partnership doing business as Sidley Austin LLP and practicing in affiliation with other Sidley Austin partnerships.

EX-101.INS 2 bf1-20180517.xml XBRL INSTANCE DOCUMENT 0000844779 2018-01-26 2018-01-26 0000844779 bf1:S000001877Member 2018-01-26 2018-01-26 2018-01-26 497 2017-09-30 BLACKROCK FUNDS 0000844779 false 2018-05-17 2018-05-17 <center>BLACKROCK FUNDSSM BlackRock Health Sciences Opportunities Portfolio (the "Fund") Supplement dated May 17, 2018 to the Summary Prospectuses, Prospectuses and Statement of Additional Information ("SAI") of the Fund, each dated January 26, 2018, as supplemented to date</center> The Fund currently operates as a diversified fund under the Investment Company Act of 1940, as amended. Accordingly, effective immediately, the following changes are made to the Fund's Summary Prospectuses, Prospectuses and SAI, as applicable: The last paragraph in the section of each Summary Prospectus entitled "Key Facts About BlackRock Health Sciences Opportunities Portfolio Principal Investment Strategies of the Fund" and the last paragraph in the sections of each Prospectus entitled "Fund Overview Key Facts About BlackRock Health Sciences Opportunities Portfolio Principal Investment Strategies of the Fund" and "Details About the Fund Principal Investment Strategies" are deleted in their entirety. The section of each Summary Prospectus entitled "Key Facts About BlackRock Health Sciences Opportunities Portfolio Principal Risks of Investing in the Fund" and the sections of each Prospectus entitled "Fund Overview Key Facts About BlackRock Health Sciences Opportunities Portfolio Principal Risks of Investing in the Fund" and "Details About the Fund Investment Risks Principal Risks of Investing in the Fund" are amended to delete "Non-Diversification Risk." <center>BLACKROCK FUNDSSM BlackRock Health Sciences Opportunities Portfolio (the "Fund") Supplement dated May 17, 2018 to the Summary Prospectuses, Prospectuses and Statement of Additional Information ("SAI") of the Fund, each dated January 26, 2018, as supplemented to date</center> The Fund currently operates as a diversified fund under the Investment Company Act of 1940, as amended. Accordingly, effective immediately, the following changes are made to the Fund's Summary Prospectuses, Prospectuses and SAI, as applicable: The last paragraph in the section of each Summary Prospectus entitled "Key Facts About BlackRock Health Sciences Opportunities Portfolio Principal Investment Strategies of the Fund" and the last paragraph in the sections of each Prospectus entitled "Fund Overview Key Facts About BlackRock Health Sciences Opportunities Portfolio Principal Investment Strategies of the Fund" and "Details About the Fund Principal Investment Strategies" are deleted in their entirety. The section of each Summary Prospectus entitled "Key Facts About BlackRock Health Sciences Opportunities Portfolio Principal Risks of Investing in the Fund" and the sections of each Prospectus entitled "Fund Overview Key Facts About BlackRock Health Sciences Opportunities Portfolio Principal Risks of Investing in the Fund" and "Details About the Fund Investment Risks Principal Risks of Investing in the Fund" are amended to delete "Non-Diversification Risk." EX-101.SCH 3 bf1-20180517.xsd XBRL TAXONOMY EXTENSION SCHEMA 000000 - Document - Document and Entity Information {Elements} link:presentationLink link:calculationLink link:definitionLink 000011 - Document - Risk/Return Supplement {Unlabeled} - BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - Risk/Return Detail Data {Elements} - BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 bf1-20180517_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 bf1-20180517_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Prospectus: Risk/Return: Document Type Document Period End Date Central Index Key Amendment Flag Document Effective Date Legal Entity Identifier Registrant Name Amendment Description Trading Symbol Document Creation Date Prospectus Date Supplement [Text Block] Supplement [Text Block] Supplement [Text Block] Document [Axis] Prospectus Series [Axis] Series S000001877 [Member] BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO Member Performance Measure [Axis] Before Taxes After Taxes on Distributions After Taxes on Distributions and Sale of Fund Shares Share Class [Axis] Share Classes C000004912 [Member] INSTITUTIONAL INSTITUTIONAL Risk/Return [Heading] Objective [Heading] Objective, Primary [Text Block] Objective, Secondary [Text Block] Expense [Heading] Expense Narrative [Text Block] Shareholder Fees Caption [Text] Shareholder Fees Column [Text] Maximum Cumulative Sales Charge (as a percentage of Offering Price) Maximum Cumulative Sales Charge (as a percentage) Maximum Sales Charge (Load) Imposed on Purchases as % of Offering Price Maximum Deferred Sales Charge (as a percentage of Offering Price) Maximum Deferred Sales Charge (as a percentage) Maximum Sales Charge on Reinvested Dividends and Distributions (as a percentage) Redemption Fee (as a percentage of Amount Redeemed) Redemption Fee (as a percentage of Amount Redeemed) Redemption Fee Redemption Fee Exchange Fee (as a percentage of Amount Redeemed) Exchange Fee Maximum Account Fee (as a percentage of Assets) Maximum Account Fee Shareholder Fee, Other Operating Expenses Caption [Text] Operating Expenses Column [Text] Management Fees (as a percentage of Assets) Distribution and Service (12b-1) Fees Distribution or Similar (Non 12b-1) Fees Component1 Other Expenses Component2 Other Expenses Component3 Other Expenses Other Expenses (as a percentage of Assets): Other Expenses Acquired Fund Fees and Expenses Total Expenses Expenses (as a percentage of Assets) Fee Waiver or Reimbursement Fee Waiver or Reimbursement Net Expenses (as a percentage of Assets) Total Annual Fund Operating Expenses After Fee Waiver Fee Waiver or Reimbursement over Assets, Date of Termination Portfolio Turnover [Heading] Portfolio Turnover [Text Block] Portfolio Turnover, Rate Expense Footnotes [Text Block] Expenses Deferred Charges [Text Block] Expenses Range of Exchange Fees [Text Block] Expense Breakpoint Discounts [Text] Expense Breakpoint, Minimum Investment Required [Amount] Expense Exchange Traded Fund Commissions [Text] Expenses Represent Both Master and Feeder [Text] Expenses Explanation of Nonrecurring Account Fee [Text] Other Expenses, New Fund, Based on Estimates [Text] Acquired Fund Fees and Expenses, Based on Estimates [Text] Expenses Other Expenses Had Extraordinary Expenses Been Included [Text] Expenses Restated to Reflect Current [Text] Expenses Not Correlated to Ratio Due to Acquired Fund Fees [Text] Expense Example [Heading] Expense Example by Year [Heading] Expense Example Narrative [Text Block] Expense Example by, Year, Caption [Text] Expense Example, with Redemption, 1 Year 1 Year Expense Example, with Redemption, 3 Years 3 Years Expense Example, with Redemption, 5 Years 5 Years Expense Example, with Redemption, 10 Years 10 Years Expense Example, No Redemption Narrative [Text Block] Expense Example, No Redemption, By Year, Caption [Text] 1 Year Expense Example, No Redemption, 1 Year Expense Example, No Redemption, 3 Years 3 Years Expense Example, No Redemption, 5 Years 5 Years Expense Example, No Redemption, 10 Years 10 Years Expense Example Footnotes [Text Block] Expense Example Closing [Text Block] Strategy [Heading] Strategy Narrative [Text Block] Strategy Portfolio Concentration [Text] Risk [Heading] Risk Narrative [Text Block] Risk Footnotes [Text Block] Risk Closing [Text Block] Risk Lose Money [Text] Risk Nondiversified Status [Text] Risk Money Market Fund [Text] Risk Not Insured Depository Institution [Text] Risk Caption Risk Column [Text] Risk [Text] Bar Chart and Performance Table [Heading] Performance Narrative [Text Block] Performance Information Illustrates Variability of Returns [Text] Performance One Year or Less [Text] Performance Additional Market Index [Text] Performance Availability Phone [Text] Performance Availability Website Address [Text] Performance Past Does Not Indicate Future [Text] Bar Chart [Heading] Bar Chart Narrative [Text Block] Bar Chart Does Not Reflect Sales Loads [Text] Annual Return Caption [Text] Caption Annual Return, Column [Text] Column Annual Return, Inception Date Inception Date Annual Return 1990 Annual Return 1991 Annual Return 1992 Annual Return 1993 Annual Return 1994 Annual Return 1995 Annual Return 1996 Annual Return 1997 Annual Return 1998 Annual Return 1999 Annual Return 2000 Annual Return 2001 Annual Return 2002 Annual Return 2003 Annual Return 2004 Annual Return 2005 Annual Return 2006 Annual Return 2007 Annual Return 2008 Annual Return 2009 Annual Return 2010 Annual Return 2011 Annual Return 2012 Annual Return 2013 Annual Return 2014 Annual Return 2015 Annual Return 2016 Annual Return 2017 Annual Return 2018 Annual Return 2019 Annual Return 2020 Bar Chart Footnotes [Text Block] Bar Chart Closing [Text Block] Bar Chart, Reason Selected Class Different from Immediately Preceding Period [Text] Bar Chart, Returns for Class Not Offered in Prospectus [Text] Year to Date Return, Label Bar Chart, Year to Date Return, Date Bar Chart, Year to Date Return Highest Quarterly Return, Label Highest Quarterly Return, Date Highest Quarterly Return Lowest Quarterly Return, Label Lowest Quarterly Return, Date Lowest Quarterly Return Performance Table Heading Performance Table Does Reflect Sales Loads Performance Table Market Index Changed Index No Deduction for Fees, Expenses, Taxes [Text] Performance Table Uses Highest Federal Rate Performance Table Not Relevant to Tax Deferred Performance Table One Class of after Tax Shown [Text] Performance Table Explanation after Tax Higher Performance Table Narrative Performance Table Footnotes, Reason Performance Information for Class Different from Immediately Preceding Period [Text] Performance Table Footnotes Performance Table Closing [Text Block] Caption Column Label 1 Year 5 Years 10 Years EX-101.PRE 6 bf1-20180517_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 g591164sidd.jpg GRAPHIC begin 644 g591164sidd.jpg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end XML 8 R1.htm IDEA: XBRL DOCUMENT

Label	Element	Value
Risk/Return:	rr_RiskReturnAbstract
Document Type	dei_DocumentType	497
Document Period End Date	dei_DocumentPeriodEndDate	Sep. 30, 2017
Registrant Name	dei_EntityRegistrantName	BLACKROCK FUNDS
Central Index Key	dei_EntityCentralIndexKey	0000844779
Amendment Flag	dei_AmendmentFlag	false
Document Creation Date	dei_DocumentCreationDate	May 17, 2018
Document Effective Date	dei_DocumentEffectiveDate	May 17, 2018
Prospectus Date	rr_ProspectusDate	Jan. 26, 2018

XML 9 R2.htm IDEA: XBRL DOCUMENT

Jan. 26, 2018
BLACKROCK FUNDS^SM BlackRock Health Sciences Opportunities Portfolio (the "Fund") Supplement dated May 17, 2018 to the Summary Prospectuses, Prospectuses and Statement of Additional Information ("SAI") of the Fund, each dated January 26, 2018, as supplemented to date The Fund currently operates as a diversified fund under the Investment Company Act of 1940, as amended. Accordingly, effective immediately, the following changes are made to the Fund's Summary Prospectuses, Prospectuses and SAI, as applicable: The last paragraph in the section of each Summary Prospectus entitled "Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Investment Strategies of the Fund" and the last paragraph in the sections of each Prospectus entitled "Fund Overview — Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Investment Strategies of the Fund" and "Details About the Fund — Principal Investment Strategies" are deleted in their entirety. The section of each Summary Prospectus entitled "Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Risks of Investing in the Fund" and the sections of each Prospectus entitled "Fund Overview — Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Risks of Investing in the Fund" and "Details About the Fund — Investment Risks — Principal Risks of Investing in the Fund" are amended to delete "Non-Diversification Risk."

Jan. 26, 2018

BLACKROCK FUNDS^SM
BlackRock Health Sciences Opportunities Portfolio
(the "Fund")

Supplement dated May 17, 2018 to the
Summary Prospectuses, Prospectuses and Statement of Additional Information ("SAI") of the Fund,
each dated January 26, 2018, as supplemented to date
The Fund currently operates as a diversified fund under the Investment Company Act of 1940, as amended. Accordingly, effective immediately, the following changes are made to the Fund's Summary Prospectuses, Prospectuses and SAI, as applicable:

The last paragraph in the section of each Summary Prospectus entitled "Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Investment Strategies of the Fund" and the last paragraph in the sections of each Prospectus entitled "Fund Overview — Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Investment Strategies of the Fund" and "Details About the Fund — Principal Investment Strategies" are deleted in their entirety.

The section of each Summary Prospectus entitled "Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Risks of Investing in the Fund" and the sections of each Prospectus entitled "Fund Overview — Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Risks of Investing in the Fund" and "Details About the Fund — Investment Risks — Principal Risks of Investing in the Fund" are amended to delete "Non-Diversification Risk."

XML 10 R3.htm IDEA: XBRL DOCUMENT

Label	Element	Value
Risk/Return:	rr_RiskReturnAbstract
Registrant Name	dei_EntityRegistrantName	BLACKROCK FUNDS
Prospectus Date	rr_ProspectusDate	Jan. 26, 2018
Supplement [Text Block]	bf1_SupplementTextBlock	BLACKROCK FUNDS^SM BlackRock Health Sciences Opportunities Portfolio (the "Fund") Supplement dated May 17, 2018 to the Summary Prospectuses, Prospectuses and Statement of Additional Information ("SAI") of the Fund, each dated January 26, 2018, as supplemented to date The Fund currently operates as a diversified fund under the Investment Company Act of 1940, as amended. Accordingly, effective immediately, the following changes are made to the Fund's Summary Prospectuses, Prospectuses and SAI, as applicable: The last paragraph in the section of each Summary Prospectus entitled "Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Investment Strategies of the Fund" and the last paragraph in the sections of each Prospectus entitled "Fund Overview — Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Investment Strategies of the Fund" and "Details About the Fund — Principal Investment Strategies" are deleted in their entirety. The section of each Summary Prospectus entitled "Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Risks of Investing in the Fund" and the sections of each Prospectus entitled "Fund Overview — Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Risks of Investing in the Fund" and "Details About the Fund — Investment Risks — Principal Risks of Investing in the Fund" are amended to delete "Non-Diversification Risk."
BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO
Risk/Return:	rr_RiskReturnAbstract
Supplement [Text Block]	bf1_SupplementTextBlock	BLACKROCK FUNDS^SM BlackRock Health Sciences Opportunities Portfolio (the "Fund") Supplement dated May 17, 2018 to the Summary Prospectuses, Prospectuses and Statement of Additional Information ("SAI") of the Fund, each dated January 26, 2018, as supplemented to date The Fund currently operates as a diversified fund under the Investment Company Act of 1940, as amended. Accordingly, effective immediately, the following changes are made to the Fund's Summary Prospectuses, Prospectuses and SAI, as applicable: The last paragraph in the section of each Summary Prospectus entitled "Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Investment Strategies of the Fund" and the last paragraph in the sections of each Prospectus entitled "Fund Overview — Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Investment Strategies of the Fund" and "Details About the Fund — Principal Investment Strategies" are deleted in their entirety. The section of each Summary Prospectus entitled "Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Risks of Investing in the Fund" and the sections of each Prospectus entitled "Fund Overview — Key Facts About BlackRock Health Sciences Opportunities Portfolio — Principal Risks of Investing in the Fund" and "Details About the Fund — Investment Risks — Principal Risks of Investing in the Fund" are amended to delete "Non-Diversification Risk."

XML 11 R4.htm IDEA: XBRL DOCUMENT

Label	Element	Value
Risk/Return:	rr_RiskReturnAbstract
Registrant Name	dei_EntityRegistrantName	BLACKROCK FUNDS
Prospectus Date	rr_ProspectusDate	Jan. 26, 2018
Document Creation Date	dei_DocumentCreationDate	May 17, 2018

EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 13 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 16 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 2 9 1 false 1 0 false 0 false false R1.htm 000000 - Document - Document and Entity Information {Elements} Sheet http://www.blackrock.com/role/DocumentDocumentandEntityInformationElements Document and Entity Information 1 false false R2.htm 000011 - Document - Risk/Return Supplement {Unlabeled} - BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO Sheet http://www.blackrock.com/role/DocumentRiskReturnSupplementUnlabeledBLACKROCKHEALTHSCIENCESOPPORTUNITIESPORTFOLIO000011 Risk/Return Supplement- BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO 2 false false R3.htm 000019 - Disclosure - Risk/Return Detail Data {Elements} - BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO Sheet http://www.blackrock.com/role/DisclosureRiskReturnDetailDataElementsBLACKROCKHEALTHSCIENCESOPPORTUNITIESPORTFOLIO000019 Risk/Return Detail Data- BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO 3 false false R4.htm 040000 - Disclosure - Risk/Return Detail Data {Elements} Sheet http://xbrl.sec.gov/rr/role/RiskReturnDetailData Risk/Return Detail Data 4 false false All Reports Book All Reports bf1-20180517.xml bf1-20180517.xsd bf1-20180517_def.xml bf1-20180517_lab.xml bf1-20180517_pre.xml http://xbrl.sec.gov/dei/2014-01-31 http://xbrl.sec.gov/rr/2012-01-31 true false ZIP 18 0001193125-18-186947-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-18-186947-xbrl.zip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�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end